Insulin contributes to fine-tuning of the pancreatic beta-cell response to glucagon-like peptide-1

Molecules and Cells

Volumn 32, Issue 4, 2011, Pages 389-395

  Moon, Mi Jin ^a   Kim, Hee Young ^a   Park, Sumi ^a   Kim, Dong Kyu ^a   Cho, Eun Bee ^a   Hwang, Jong Ik ^a   Seong, Jae Young ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

cells; CAMP; Erk; GLP 1; Insulin; RTK

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CYCLIC AMP; EPIDERMAL GROWTH FACTOR RECEPTOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; ISOQUINOLINES; NAPHTHALENES; ONCOGENE PROTEIN V-AKT; PHOSPHONIC ACIDS; PHOSPHORYLATION; QUINAZOLINES; RATS; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, AMPA; TETRAZOLES; TYRPHOSTINS;

EID: 84855694178     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-011-0157-9     Document Type: Article

References (34)

1. Ahmad, F., Lindh, R., Tang, Y., Weston, M., Degerman, E., and Manganiello, V.C. (2005). Insulin-induced formation of macromolecular complexes involved in activation of cyclic nucleotide phosphodiesterase 3B (PDE3B) and its interaction with PKB. Biochem. J. 404, 257-268. (Pubitemid 46849597)
2. Best, C.H., and Haist, R.E. (1941). The effect of insulin administration on the insulin content of the pancreas. J. Physiol. 100, 142-146.
3. Bregenholt, S., Moldrup, A., Blume, N., Karlsen, A.E., Nissen Friedrichsen, B., Tornhave, D., Knudsen, L.B., and Petersen, J.S. (2005). The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro. Biochem. Biophys. Res. Commun. 330, 577-584. (Pubitemid 40417684)
4. Buteau, J., Foisy, S., Joly, E., and Prentki, M. (2003). Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52, 124-132. (Pubitemid 36042116)
5. Creutzfeldt, W., and Ebert, R. (1985). New developments in the incretin concept. Diabetologia 28, 565-573. (Pubitemid 15017390)
6. Da Silva Xavier, G., Rutter, J., and Rutter, G.A. (2004). Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of preproinsulin and pancreatic duodenum homeobox 1 gene expression by glucose. Proc. Natl. Acad. Sci. USA 101, 8319-8324. (Pubitemid 38736573)
7. Drucker, D.J., Philippe, J., Mojsov, S., Chick, W.L., and Habener, J.F. (1987). Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. USA 84, 3434-3438. (Pubitemid 17085418)
8. Fehmann, H.C., Goke, R., and Goke, B. (1995). Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose- dependent insulin releasing polypeptide. Endocr. Rev. 16, 390-410
9. Hansotia, T., and Drucker, D.J. (2005). GIP and GLP-1 as incretin hormones: Lessons from single and double incretin receptor knockout mice. Regul. Pept. 128, 125-134. (Pubitemid 40380913)
10. Härndahl, L., Jing, X.J., Ivarsson, R., Degerman, E., Ahrén, B., Manganiello, V.C., Renström, E., and Holst, L.S. (2002). Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin. J. Biol. Chem. 277, 37446-3755.
11. Harbeck, M.C., Louie, D.C., Howland, J., Wolf, B.A., and Rothenberg, P.L. (1996). Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells. Diabetes 45, 711-717. (Pubitemid 26168581)
12. Huotari, M.A., Palgi, J., and Otonkoski, T. (1998). Growth factormediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: Identification of betacellulin as a novel beta-cell mitogen. Endocrinology 139, 1494-1499. (Pubitemid 28513801)
13. Jorgensen, R., Kubale, V., Vrecl, M., Schwartz, T.W., and Elling, C.E. (2007). Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s). J. Pharmacol. Exp. Ther. 322, 148-154. (Pubitemid 46956350)
14. Kerchner, K.R., Clay, R.L., Mccleery, G., Watson, N., Mcintire, W.E., Myung, C.S., and Garrison, J.C. (2004). Differential sensitivity of phosphatidylinositol 3-kinase p110gamma to isoforms of G protein betagamma dimers. J. Biol. Chem. 279, 44554-44562. (Pubitemid 39430862)
15. Kieffer, T.J., and Habener, J.F. (1999). The glucagon-like peptides. Endocr. Rev. 20, 876-913. (Pubitemid 30647076)
16. Kitamura, T., Kitamura, Y., Kuroda, S., Hino, Y., Ando, M., Kotani, K., Konishi, H., Matsuzaki, H., Kikkawa, U., Ogawa, W., et al. (1999). Insulin-induced phosphorylation and activa-tion of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell. Biol. 19, 6286-6296. (Pubitemid 29399333)
17. Kjems, L.L., Holst, J.J., Volund, A., and Madsbad, S. (2003). The influence of GLP-1 on glucose-stimulated insulin secretion: Effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52, 380-386. (Pubitemid 36173193)
18. Koranyi, L., James, D.E., Kraegen, E.W., abd Permutt, M.A. (1992). Feedback inhibition of insulin gene expression by insulin. J. Clin. Invest. 89, 432-436.
19. Kulkarni, R.N., Brüning, J.C., Winnay, J.N., Postic, C., Magnuson, M.A., and Kahn, C.R. (1999). Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96, 329-339. (Pubitemid 29077587)
20. Leibiger, I.B., Leibiger, B., Moede, T., and Berggren, P.O. (1998). Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol. Cell 1, 933-938. (Pubitemid 128379078)
21. Leibiger, I.B., Leibiger, B., and Berggren, P.O. (2002). Insulin feedback action on pancreatic beta-cell function. FEBS Lett. 532, 1-6. (Pubitemid 35375856)
22. Leibiger, B., Moede, T., Uhles, S., Barker, C.J., Creveaux, M., Domin, J., Berggren, P.O., and Leibiger, I.B. (2010). Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for glucosestimulated insulin secretion. FASEB J. 24, 1824-1837.
23. Loreti, L., Dunbar, J.C., Chen, S., and Foa, P.P. (1974). The autoregulation of insulin secretion in the isolated pancreatic islets of lean (obOb) and obese-hyperglycemic (obob) mice. Diabetologia 10, 309-315.
24. Natarajan, K., and Berk, B.C. (2006). Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. Methods Mol. Biol. 332, 51-77.
25. Nauck, M.A. (2011). Incretin-based therapies for type 2 diabetes mellitus: Properties, functions, and clinical implications. Am. J. Med. 124, S3-18.
26. Nauck, M., Stockmann, F., Ebert, R., and Creutzfeldt, W. (1986). Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29, 46-52. (Pubitemid 16162741)
27. Nauck, M.A., Heimesaat, M.M., Orskov, C., Holst, J.J., Ebert, R., and Creutzfeldt, W. (1993). Preserved incretin activity of glucagon- like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 91, 301-307. (Pubitemid 23037285)
28. Oh, D.Y., Song, J.A., Moon, J.S., Moon, M.J., Kim, J.I., Kim, K., Kwon, H.B., and Seong, J.Y. (2005). Membrane-proximal region of the carboxyl terminus of the gonadotropin-releasing hormone receptor (GnRHR) confers differential signal transduction between mammalian and nonmammalian GnRHRs. Mol. Endocrinol. 19, 722-731. (Pubitemid 40349443)
29. Shepherd, P.R. (2004). Secrets of insulin and IGF-1 regulation of insulin secretion revealed. Biochem. J. 377, e1-2.
30. Sonoda, N., Imamura, T., Yoshizaki, T., Babendure, J.L., Lu, J.C., and Olefsky, J.M. (2008). Beta-Arrestin-1 mediates glucagonlike peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc. Natl. Acad. Sci. USA 105, 6614-6619. (Pubitemid 351754555)
31. Van Schravendijk, C.F., Foriers, A., Van Den Brande, J.L., and Pipeleers, D.G. (1987). Evidence for the presence of type I insulin- like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121, 1784-1788. (Pubitemid 18012784)
32. Withers, D.J., Gutierrez, J.S., Towery, H., Burks, D.J., Ren, J.M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G.I., et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904. (Pubitemid 28157668)
33. Yajima, H., Komatsu, M., Schermerhorn, T., Aizawa, T., Kaneko, T., Nagai, M., Sharp, G.W., and Hashizume, K. (1999). cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes 48, 1006-1012. (Pubitemid 29226346)
34. Zawalich, W.S., Karl, R.C., Ferrendelli, J.A., and Matschinsky, F.M. (1975). Factors governing glucose induced elevation of cyclic 3'5' AMP levels in pancreatic islets. Diabetologia 11, 231-235.